Filter
340
Text search:
formulations
Featured
Recommendations
51
New Publications
84
Language
Document type
No document type
174
Guidelines
83
Studies & Reports
48
Manuals
15
Strategic & Response Plan
7
Infographics
4
Fact sheets
4
Training Material
3
App
1
Resource Platforms
1
Countries / Regions
India
16
Kenya
15
Global
11
Western and Central Europe
8
Ghana
7
Malawi
7
South Africa
6
Tanzania
5
Rwanda
5
Bangladesh
5
Sierra Leone
4
Nigeria
4
Senegal
4
Ethiopia
4
Syria
4
Africa
4
Burkina Faso
3
Nepal
3
Zambia
3
Botswana
3
South–East Asia Region
3
Latin America and the Carribbean
3
Eastern Europe
3
Congo, Democratic Republic of
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Cameroon
2
Uganda
2
Zimbabwe
2
Haiti
2
Benin
2
Middle East and North Africa
2
Russia
2
France
2
Guinea
1
Liberia
1
Niger
1
Philippines
1
Pakistan
1
South Sudan
1
Afghanistan
1
Cambodia
1
Eswatini/ Swaziland
1
Colombia
1
Madagascar
1
Myanmar / Burma
1
Sri Lanka
1
Yemen
1
East and Southern Africa
1
Bhutan
1
Venezuela
1
Congo-Brazzaville
1
Tajikistan
1
Authors & Publishers
Publication Years
Category
Countries
91
Clinical Guidelines
75
Public Health
21
Women & Child Health
21
Key Resources
13
Pharmacy & Technologies
6
Capacity Building
3
Toolboxes
HIV
50
TB
34
Pharmacy
23
COVID-19
22
Mental Health
17
AMR
17
NTDs
15
NCDs
10
Caregiver
9
Rapid Response
8
Polio
6
Disability
5
Conflict
5
Ebola & Marburg
4
Planetary Health
4
2.0 Rapid Response
4
Refugee
3
Malaria
3
Natural Hazards
2
Specific Hazards
2
Cholera
1
Zika
1
Global Health Education
1
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
Other disorders
Chapter H.5.1
Au Sénégal, la LAV repose principalement sur deux interventions majeures: la promotion de l’utilisation des Moustiquaires Imprégnées d’Insecticide à longue durée d’Action (MILDA) et l’Aspersion Intra Domiciliaire d’insecticide à effet rémanent (AID). Même si ces deux interventions
...
Start Free Stay Free AIDS Free - 2020 report
recommended
This progress report reviews recent gains, new developments and remaining challenges as countries approach the 2020 targets of the Start Free Stay Free AIDS Free framework.
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch
...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti
...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from
...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim
...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio
...
WHO Secretariat Information paper July 2016
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac
...
Lessons from the STEP-TB Project.
Accessed November 2017.
